OAM
ROIV icon

Oxford Asset Management’s Roivant Sciences ROIV Stock Holding History

Oxford Asset Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-30,134
Closed -$456K – 712
2025
Q3 		$456K Sell
30,134
-18,987
-39% -$235K 0.15% 233
2025
Q2 		$554K Buy
+49,121
New +$532K 0.18% 181

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Oxford Asset Management's ROIV Position: Q4 2025 in Review

Oxford Asset Management sold out of Roivant Sciences (ROIV) in Q4 2025, closing a stake of 30,134 shares — an estimated $456K sold.

Oxford Asset Management first reported a position in ROIV in Q2 2025 and held it in 2 quarters. The position peaked at $554K in Q2 2025. 397 funds tracked by Wall St. Rank hold ROIV as of Q4 2025.

  • Oxford Asset Management reported no remaining Roivant Sciences position as of Q4 2025 after selling out during the quarter.
  • Oxford Asset Management sold 30,134 Roivant Sciences shares in Q4 2025, an estimated $456K.
  • Oxford Asset Management first reported a position in Roivant Sciences in Q2 2025 and held it in 2 quarters.
  • Oxford Asset Management's Roivant Sciences position peaked at $554K in Q2 2025.
  • 397 funds tracked by Wall St. Rank held Roivant Sciences as of Q4 2025.

Based on Oxford Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.